ASHLEA LUCERO: Open Payments
NPI 1568237485 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$390 in 16 payments from 9 companies in 2025. Trend: 2023 $19 · 2024 $759 · 2025 $390
Food & beverage: $379Education: $12
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $161 |
| Exact Sciences Corporation | 4 | $66 |
| Astellas Pharma US Inc | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $34 |
| Lundbeck LLC | 1 | $21 |
| Novo Nordisk Inc | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| PFIZER INC. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: AIRSUPRA, Veozah, Kerendia, The Cologuard Plus Collection Kit, REXULTI, Ozempic, FARXIGA, MOUNJARO.
Industry payments across NM — which companies pay providers there.
